Skip to content

Released May 6, 2022, before the open

10-Q filed May 6, 2022, 36 days after period end · 0000950170-22-007997

Q1 2022 · 10-Q
Revenue$106.42M+0.8% vs Q1 2021−14.9% vs Q4 2021
Net Income-$4.46MN/M vs Q1 2021N/M vs Q4 2021
EPS Diluted-$0.22N/M vs Q1 2021no prior Q4 2021 on file
Gross Profit$78,100,000−2.0%
Operating Income-$3,078,000N/M
Operating Cash Flow-$7,709,000N/M
Free Cash Flowderived-$13,038,000N/M
Margins · derived
Gross margin73.4%−2.1 pt vs Q1 2021
Operating margin-2.9%−0.1 pt vs Q1 2021
Net margin-4.2%+1.3 pt vs Q1 2021

What the release said

The release

Same quarter

MetricQ1 2022Q1 2021Q1 2020Q1 2019
Revenue$106.42M$105.59M$104.82M$109.11M
Net Income-$4.46M-$5.82M$25.67M$897.00K
EPS Diluted-$0.22-$0.30$1.32$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR